1 / 8

Gene repair in murine hematopoietic stem cells (NGEC Component 6)

Alex, Jordan, and Byoung. Yupeng. Gene repair in murine hematopoietic stem cells (NGEC Component 6). Aim 1 : Develop murine X-linked severe combined immunodeficiency (XSCID) models for I-SceI vs. engineered I-AniI gene repair.

vicki
Download Presentation

Gene repair in murine hematopoietic stem cells (NGEC Component 6)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Alex, Jordan, and Byoung Yupeng Gene repair in murine hematopoietic stem cells (NGEC Component 6) • Aim 1: Develop murine X-linked severe combined immunodeficiency (XSCID) models for I-SceI vs. engineered I-AniI gene repair. • Aim 2: Develop and test non-integrating lentiviral (NIL) vectors for concurrent HE and repair template delivery. • Aim 3: Test gene repair using NIL vectors in primary cells from XSCID mice. • Aim 4: Engineer Ani-I for Btk gene repair (in XID/Tec-/- model of human X-linked agammaglobulinemia; XLA). • Aim 5: Test gene repair in XID mice in the presence vs. absence of the cis-linked selectable marker, MGMTP140K.

  2. TGA Lox pGK Neo pA Lox Exon 6 I-Ani1 GGTCATTTTCCTTGTTTGTTACAGAGAATCCTTCCTTGTTTTCATGA... CCAGTAAAAGGAACAAACAATGTCTCTTAGGAAGGAACAAAAGTACT... I-Ani1 Recognition Sequence (or I-Sce1 or WT 14/19 I-Ani1) BspH1

  3. XSCID Common g-chain Knock-in Models Testing NIL-driven DNA Repair in HSC and In vitro B Lymphoid Cell Lines 1. Model % WT HSC required for phenotypic correction in vivo- Alex/Jordan 2. Establish quantitative assay of repair frequency- Alex 3. Test NIL vectors in vitro and in vivo using Sce-XSCID model- Alex/Jordan/Byoung 4. Expand, phenotype and backcross Ani-XSCID model- Alex Proof of Concept: Gene Repair in vivo in following NIL infection of purified hematopoietic stem cells (HSC).

  4. Non-integrating lentiviral (NIL) vectors for concurrent HE and repair template delivery. NIL vectors generated using mutant packaging construct: psPAX2(int-) Integrase mutated to an inactive form via D64V amino acid substitution) Byoung Ryu and Vector Core

  5. XSCID Common g-chainEx6TGA Knock-in Models TGA FRT pGK Neo pA FRT Exon 6 I-Sce1 GGTCATTTTCCTTGTTTGTTATAGGGATAACAGGGTAATTTTCATGA... CCAGTAAAAGGAACAAACAATATCCCTATTGTCCCATTAAAAGTACT... I-SceI Wild Type / 14:19 I-AniI GGTCATTTTCCTTGTTTGTTACAGAGAAACCTCCTCAGTTTTCATGA... GGTCATTTTCCTTGTTTGTTACAGAGAATCCTTCCTTGTTTTCATGA... CCAGTAAAAGGAACAAACAATGTCTCTTTGGAGGAGTCAAAAGTACT... CCAGTAAAAGGAACAAACAATGTCTCTTAGGAAGGAACAAAAGTACT... I-AniI BspH1

  6. XSCID Common g-chainEx6TGA Knock-in Models TGA FRT pGK Neo pA FRT Exon 6 I-Sce1 GGTCATTTTCCTTGTTTGTTATAGGGATAACAGGGTAATTTTCATGA... CCAGTAAAAGGAACAAACAATATCCCTATTGTCCCATTAAAAGTACT... I-SceI Wild Type / 14:19 I-AniI GGTCATTTTCCTTGTTTGTTACAGAGAATCCTTCCTTGTTTTCATGA... CCAGTAAAAGGAACAAACAATGTCTCTTAGGAAGGAACAAAAGTACT... BspH1

  7. a) b) c) Figure 3: Mouse SCID model for gene correction in IL2Rg-deficient strains. Each strain, generated by homologous recombination, carries a premature stop codon at the beginning of Exon 6 which will abrogate surface expression of the g-chain which is a component in multiple cytokine receptors required for efficient hematopoiesis. In the absence of the g-chain, development of both B- and T-lymphocytes is blocked at an early stage. Strain a) and b) carry the engineered HE target sites recognized by I-AniI and I-SceI placed immediately upstream of the splice acceptor site. Strain c) retains the wild-type sequence, which is a 14/19 near-consensus target sequence for I-AniI cleavage. These mouse strains will allow for proof of concept type experiments within an optimized system for analyzing gene repair, as well as providing an in-vivo target for evaluating the ability, in relation to highly efficient natural HEs, to successfully engineer an artificially evolved HE capable of gene repair. References: 1. Hacein-Bey-Abina S., et al. Science. 2003. 302(5644):415-9 2. Smith GR. Annu Rev Genet. 2001. 35:243-74 3. Doolittle RF. Proc Natl Acad Sci USA. 1993. 90:5379-81 4. Arakawa H., et al. Science. 2002. 295(5558):1301-6 5. Wang L., et al. Proc Natl Acad Sci USA. 2004. 101(48):16745-9 6. Mahadevaiah SK., et al. Nat Genet. 2001. 27(3):271-6

More Related